Bank Of America Upped Its Forecast For Stocks — Just Not The Ones You ThinkInvestors Business Daily • 05/23/23
Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023The Motley Fool • 05/19/23
Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual MeetingAccesswire • 05/19/23
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%The Motley Fool • 05/18/23
Moderna gets shot in the arm from unexpected 1Q profit, COVID vaccine sales outlookProactive Investors • 05/04/23
Moderna Jumps After Unexpectedly Reporting Profit In The First QuarterInvestors Business Daily • 05/04/23